QuadraMed and e-MDs Provide University Medical Center at Princeton with an Interoperable EHR for Physician Clinics

QuadraMed Corporation (NASDAQ: QDHC), a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced that New Jersey-based, University Medical Center at Princeton, a unit of Princeton HealthCare System, will offer an ambulatory electronic health record to its affiliated physician practices. The award-winning EHR solution, supplied by e-MDs in collaboration with QuadraMed, will provide clinicians with access to complete patient information across the continuum of care.

“As a QuadraMed customer for over a decade, we naturally turned to them for an EHR solution that would fulfill our vision of coordinated care based upon a longitudinal patient record,” said Nick Thimis, CIO of Princeton Healthcare Systems. “Today, affiliated physician practices can easily access patient information stored within our hospital’s clinical systems for improved decision-making and patient care.”

The e-MDs CCHIT Certified® EHR solution has earned top rankings in objective evaluations sponsored by independent third parties such as the American College of Physicians and the American Academy of Family Physicians.

“I can’t overemphasize the importance of linking inpatient and ambulatory patient history to help ensure greater safety and quality of care,” said Michael Stearns, M.D., president and CEO of e-MDs. “In the past, the technical complexities of integration has limited health information exchange between hospitals and physician practices. Our partnership with QuadraMed resolves the issue with built-in interoperability, enabling access to secure, accurate and updated patient healthcare information to physicians across the continuum of care. This collaboration, coupled with Princeton HealthCare System’s record of excellence, represents a significant step toward the nationwide vision of community based healthcare.”

“Through our partnership with e-MDs, we offer the University Medical Center at Princeton a complete suite of healthcare technology solutions to help them meet the 'meaningful use' requirements of the American Recovery and Reinvestment Act (ARRA) and help them attain stimulus funds,” said Duncan W. James, president and CEO of QuadraMed. “e-MDs’ ambulatory EHR solution is a perfect complement to the hospital’s QuadraMed EHR solution, enabling the organization to increase their return on investment and realize additional improvements in patient safety and care.”

About e-MDs

e-MDs is a leading developer of healthcare software solutions and is headquartered in Austin, Texas. The company, founded in 1996 by a primary care physician, remains physician-managed and actively participates in national health information technology and interoperability efforts. e-MDs Solution Series™, with more than 23,000 users nationwide, is the standard for affordable and integrated EHR and Practice Management software solutions including clinical, financial and document management modules designed to automate medical practice processes and chart management. The product is 2008 CCHIT Certified and is designed to improve care, reduce errors and simplify business so that time spent with patients is time billed and coded properly. For more information, please visit e-MDs.

About QuadraMed Corporation

QuadraMed® – (NASDAQ: QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline processes, ensure compliance and help healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words “believe,” “expect,” “target,” “goal,” “project,” “anticipate,” “predict,” “intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.